|
⚲
|
| Keyboard |
| Nextech V Oncology SCS SICAV-SIF
✚
|
|
|---|---|
| CIK # | 0001712922 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001712922] | |
| 4 | [0001712922] | |
| D | [0001712922] | |
| SC 13G | [0001712922] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| PMV Pharmaceuticals Inc | |
| Nextech V Oncology SCS SICAV-SIF | |
| Lips Thomas | |
| Bleyer Dalia | |
| Detournay Philippe | |
| Nextech V GP Sa RL |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2020-09-29 | Conversion | 1,768,023 | ||
|
PMV Pharmaceuticals Inc PMVP
Common Stock
|
2020-09-29 | Conversion | 760,267 | ||
|
PMV Pharmaceuticals Inc PMVP
Series D Preferred Stock · derivative
|
2020-09-29 | Conversion | 760,267 | $0.00 | |
|
PMV Pharmaceuticals Inc PMVP
Series C Preferred Stock · derivative
|
2020-09-29 | Conversion | 1,768,023 | $0.00 |